Answers are grounded in this paper and cite their sources.
Dear Editor,While common adverse events associated with sodium-glucose cotransporter-2 inhibitors—such as genitourinary infections and volume depletion—are well-characterized, rare immune-mediated cutaneous manifestations are increasingly recognized in post-marketing surveillance...
No takes yet. Share an insight, caveat, or question.
Provenzano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: